Intelligence

#AI / data analytics / healthtech / informatics #Analysis #Animal models #Biochemistry #Biomarkers #Business #Cell / tissue culture #Cell culture #Cell therapy #Cellular & Molecular biology #Clinical specialities #Clinical trials #Drug development #Drug discovery #Drug targets #Gene therapy #Genetics / genomes #High Content Screening #High throughput screening #Imaging #Immunology #Molecular medicine #Oncology #Preclinical #Regulatory #RNA #Screening #Stem cells #Toxicology #Translational #Translational chemistry

Reshaping the Landscape of Cancer Drug Discovery and Development

Reshaping the Landscape of Cancer Drug Discovery and Development By Dr Paolo Paoletti The landscape of cancer drug discovery and development is shifting, adjusting and reshaping itself in response to the huge rush of scientific knowledge which has come to the fore over the past few decades. Read More

#Archive

#Animal models #Biologics / Biotechnology #Biomarkers #Business #Cellular assays #Clinical specialities #Clinical trials #Drug development #Drug discovery #Immunology #Immunology / Virology & Vaccines #Lead discovery #Lead optimisation #Pharmokinetics #Preclinical #Regulatory #RNA #Screening #Target validation #Therapeutics #Toxicology

Designing animal models for evaluation of therapeutic and vaccine candidates for emerging and biodefence-related pathogens

Designing animal models for evaluation of therapeutic and vaccine candidates for emerging and biodefence-related pathogens By Dr Colleen Jonsson and Dr Peter Silvera While a number of promising drug therapies and vaccines have been identified for safeguarding bioterrorism organisms and diseases, further development requires well characterised animal models… Read More

#Archive

#Analysis #Assay development optimisation & technology #Biomarkers #Clinical specialities #Clinical trials #Drug development #Drug discovery #Drug targets #Flow Cytometry #Gene therapy #Genetics / genomics #Genomics #Lead discovery #Metabolomics #Molecular medicine #PCR #Protein chemistry / Proteomics #Regulatory #RNA #Toxicology

Molecular Diagnostics in Drug Development – The changing face of pharmaceutical discovery

Molecular Diagnostics in Drug Development – The changing face of pharmaceutical discovery By Dr Berwyn Clarke Clinical drug development is moving into an era where high technology new diagnostics are key to the development of the majority of new drugs. Markers are now available that… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Assay development optimisation & technology #Automation / robotics #Biobanking #Biologics / Biotechnology #Biomarkers #Business #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Drug development #Drug discovery #Enabling technologies #High Content Screening #High throughput screening #Lead discovery #Molecular medicine #Patent Law #Protein chemistry / Proteomics #RNA #Screening #Stem cells #Therapeutics #Translational #Translational chemistry

Automated Biobanking – The next big step for biorespositories

Automated Biobanking – The next big step for biorespositories By Dr John Comley As a significant proportion of the many newly established national, regional and disease-specific biobanks or biorespositories contemplate how they will enable enhanced sample integrity, tracking and audit trail, there has never been a more… Read More

#Archive

#ADME / Tox #AI / data analytics / healthtech / informatics #Analysis #Assay development & optimisation #Assay development optimisation & technology #Automation / robotics #Biomarkers #Business #Cellular assays #Chemistry #Computational chemistry #Drug development #Drug discovery #Drug targets #Genetics / genomes #Genomics #High Content Screening #High throughput screening #Lead discovery #Medicinal chemistry #Metabolomics #PCR #Protein chemistry / Proteomics #RNA #Screening #System biology #Systems biology #Target validation #Toxicology

Tools for Target Identification, Validation and Biomarker Discovery

Tools for Target Identification, Validation and Biomarker Discovery By Dr Paul Denny-Gouldson As automation in the drug discovery arena increases then so does the amount and complexity of the data. We discuss an emerging solution that now integrates various technologies to provide a scientific data intelligence tool… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Automation / robotics #Business #Cell / tissue culture #Chemical engineering #Chemistry #Clinical specialities #Drug development #Drug discovery #Enabling technologies #High Content Screening #Lead discovery #Mass spectrometry / NMR #Regulatory #RNA #System biology #Systems biology

Enabling Collaborative Science via the Integration of Analytical Data into Organisational Systems

Enabling Collaborative Science via the Integration of Analytical Data into Organisational Systems By Mark Bayliss The storage of data drawn from the analytical process has for years been the stumbling block in the overall ‘knowledge management’ of the discovery process. This article argues that current… Read More

#Archive

#AI / data analytics / healthtech / informatics #Business #Cell culture #Chemical engineering #Chemistry #High Content Screening #Regulatory #RNA #Target validation

Changing the Model for Lab Equipment Maintenance and Asset Management

Changing the Model for Lab Equipment Maintenance and Asset Management By Martin Long A large section of the Pharmaceutical, Biotech and supporting industries are currently driving aggressive cost-saving initiatives throughout their operations to remain competitive, and deliver shareholder value. One such area is the cost associated… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Assay development optimisation & technology #Automation / robotics #Biochemistry #Biomarkers #Business #Cell therapy #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Computational chemistry #Drug development #Drug discovery #Gene therapy #Genetics / genomes #Genetics / genomics #Genomics #High Content Screening #High throughput screening #Immunology #In Silico Biology #Lead discovery #Mass spectrometry / NMR #Metabolomics #Molecular medicine #Oncology #Orphan drugs #Pathology #PCR #Pharmacogenomics #Pharmacology #Protein chemistry / Proteomics #Regulatory #RNA #Screening #Sequencing #Stem cells #System biology #Systems biology #Therapeutics #Translational #Translational chemistry

Personalised Medicine – Innovation and empowerment or exuberant hyperbole?

Personalised Medicine – Technological innovation and patient empowerment or exuberant hyperbole? By Adam W. Culbertson, Dr Stephen J. Valentine and Dr Stephen Naylor The current paradigm of modern healthcare focuses on patient symptoms, subsequent diagnosis and corresponding treatment of the specific disease(s). Escalating healthcare costs and a… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Animal models #Assay development optimisation & technology #Automation / robotics #Biochemistry #Business #Cellular & Molecular biology #Chemical engineering #Chemistry #Clinical specialities #Drug development #Drug discovery #Drug targets #Genetics / genomes #Genomics #High throughput screening #Pharmacology #Preclinical #Regulatory #RNA #Screening #Sequencing #System biology #Systems biology #Target validation

The evolving world of drug discovery data integration in the pharmaceutical industry

The evolving world of drug discovery data integration in the pharmaceutical industry Dr David Sedlock The world of drug discovery has been impacted significantly by an ever evolving use of computer systems during the past 25 years with the greatest change occurring during the past 10 years… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analytical chemistry #Animal models #Assay development optimisation & technology #Automation / robotics #Cell culture #Cellular assays #Chemistry #Clinical trials #Computational chemistry #Drug development #Drug discovery #Drug targets #Enabling technologies #High Content Screening #High throughput screening #Lead discovery #Mass spectrometry / NMR #Molecular medicine #Organic chemistry #Precision medicine #RNA #Screening #System biology #Systems biology #Therapeutics #Translational #Translational chemistry

Establishment of an open access compound management facility

Establishment of an open access compound management facility By David Camp This article covers the establishment of an open access compound management facility in Australia to stimulate applied, basic and translational biomedical research. The paradigm for probing biological processes and drug discovery via small molecules has… Read More

#Archive

#ADME / Tox #Automation / robotics #Biomarkers #Business #Cell therapy #Cellular & Molecular biology #Chemistry #Clinical specialities #Clinical trials #Drug development #Drug discovery #Drug targets #Gene therapy #Genetics / genomes #Genomics #Imaging #Lead discovery #Molecular medicine #Oncology #Pathology #Pharmokinetics #Preclinical #Protein chemistry / Proteomics #Regulatory #RNA #Target validation #Therapeutics #Toxicology #Translational #Translational chemistry

Positron Emission Tomography (PET) – Shining a light on human disease

By Dr Jean-Luc Vanderheyden As the experience and advances in Positron Emission Tomography (PET) imaging grows, so does the belief that this technology can have a key role to play in ushering in an era of personalised medicine while also offering an enormous contribution in… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Assay development & optimisation #Assay development optimisation & technology #Automation / robotics #Cellular & Molecular biology #Cellular assays #Drug development #Drug discovery #Enabling technologies #High Content Screening #High throughput screening #Lead discovery #Lead optimisation #RNA #Screening #Stem cells #Toxicology

Serial vs Direct Dilution – Time to apply new thinking to IC50 determination and dose-response analysis?

Serial vs Direct Dilution – Time to apply new thinking to IC50 determination and dose-response analysis? By Dr John Comley The serial dilution method is standard practice in the preparation of doseresponse series for IC50 determination. However, it is well recognised that inadequacies in the liquid handling… Read More

#Archive

#AI / data analytics / healthtech / informatics #Automation / robotics #Business #Chemistry #Clinical specialities #Clinical trials #Drug development #Drug discovery #Drug targets #Gene therapy #Molecular medicine #Preclinical #Regulatory #RNA #Toxicology

The Art of Collaboration – Partnering and Licensing at Novartis

By Anthony Rosenberg Partnering and licensing have become paramount in a pharmaceutical industry that is under inordinate pressure to fill pipelines and increase the number of approved new molecular entities. This article discusses how Novartis has gone about addressing this issue. There is a great deal… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Animal models #Assay development optimisation & technology #Automation / robotics #Business #Cellular assays #Chemical engineering #Chemistry #Clinical trials #Combinatorial chemistry #Computational chemistry #Drug development #Drug discovery #Drug targets #Enabling technologies #High Content Screening #High throughput screening #Lead discovery #Lead optimisation #Medicinal chemistry #Molecular medicine #Regulatory #RNA #Screening #System biology #Target validation

Lean Thinking for Drug Discovery – Better Productivity for Pharma

Lean Thinking for Drug Discovery – Better Productivity for Pharma By Dr Edward W. Petrillo Success in drug discovery controls the success of the pharmaceutical enterprise. The molecular structure of every drug candidate, and the body of knowledge that will guide its use in the treatment of disease,… Read More

#Archive

#Academic #Analysis #Automation / robotics #Biochemistry #Business #Cellular & Molecular biology #Chemistry #Clinical specialities #Clinical trials #Drug development #Drug discovery #Genomics #High Content Screening #Lead discovery #Lead optimisation #Molecular medicine #Oncology #Patent Law #Preclinical #Regulatory #RNA #System biology #Systems biology #Target validation #Therapeutics #Toxicology

India – Global pharmaceutical R&D powerhouse or contract research workshop?

India – Global pharmaceutical R&D powerhouse or contract research workshop? By Dr Matthew Howard In response to the ever-increasing costs of drug discovery and development, pharmaceutical industry leaders must constantly seek to increase productivity while simultaneously reducing costs and maintaining quality. Globalisation of drug discovery may… Read More

#Archive

#Animal models #Assay development optimisation & technology #Automation / robotics #Business #Cellular & Molecular biology #Cellular assays #Drug development #Drug discovery #Drug targets #High throughput screening #Lead discovery #Molecular medicine #Regulatory #RNA #Screening #Target validation

Sharing Risks and Rewards – Basis for a turnkey pharma-biotech alliance in osteoarthritis

Sharing Risks and Rewards – Basis for a turnkey pharma-biotech alliance in osteoarthritis Dr Andre Hoekema In June 2006, Galapagos and GlaxoSmithKline’s Center of Excellence for External Drug Discovery (CEEDD) formed a multi-year worldwide alliance to discover and develop novel drugs for osteoarthritis. The focus of… Read More

#Archive